Answers are grounded in this paper and cite their sources.
In vitro assays show citronella oil exhibits strong antifungal and moderate antibacterial activity, indicating potential for antimicrobial applications.
Introduction: Antimicrobial resistance poses a significant global health threat in the 21st century. The COVID-19 pandemic, caused by SARS-CoV-2, has further emphasized the need for novel and effective alternative therapeutics, especially from natural sources. Despite the known bioactivity of citronella oil, its potential as a broad-spectrum antimicrobial and antiviral agent remains underexplored. This study aimed to evaluate the antibacterial, antifungal, and anti-viral potential of commercially produced citronella oil using in vitro and in silico approaches. Methods: The chemical constituents of citronella oil were identified using gas chromatography-mass spectrometry (GC-MS). Antibacterial activity was assessed using the disk diffusion method, while antifungal efficacy was evaluated via the poison plate method. In silico techniques, includ-ing molecular docking, ADMET profiling, density functional theory, molecular dynamics simula-tion, principal component analysis, and dynamic cross-correlation mapping, were used to predict antiviral activity against the SARS-CoV-2 main protease (Mpro). Results: GC-MS identified 30 compounds in citronella oil. Antibacterial assays demonstrated no-table inhibition against Bacillus cereus (32 μL/mL), Staphylococcus aureus (128 μL/mL), Esche-richia coli (8 μL/mL), and Klebsiella pneumoniae (32 μL/mL). The oil achieved 100% mycelial growth inhibition of Fusarium oxysporum at 70 μL/mL. Molecular docking identified three com-pounds- CID-91697, CID-5367548, and CID-609268- with higher binding affinities than the ref-erence drug shikonin. Computational analyses highlighted CID-91697 as the most promising can-didate for SARS-CoV-2 Mpro inhibition. Discussion: The results show that commercially available citronella oil has strong antifungal properties and moderate antibacterial properties. This suggests that it could be a natural broad-spectrum antimicrobial agent. Furthermore, in silico analyses indicate that CID-91697 may func-tion as a potential inhibitor of SARS-CoV-2 Mpro, thus underscoring its significance in antiviral drug discovery. Overall, the results from both in vitro and computer-based studies make a solid case for further preclinical research.
No takes yet. Share an insight, caveat, or question.
Parvez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: